FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015680101> ?p ?o ?g. }

• W3015680101 abstract "Background: According to the World Health Organization (WHO), diabetes mellitus is considered the 7th leading cause of death as of 2016, while almost half of all deaths related to high blood glucose occur before the age of 70. According to the 2019 American Diabetes Association’s (ADA) guidelines, metformin is the firstline treatment for patients with Type 2 diabetes. Additional therapy is dependent on multiple patient-specific factors, including cardiovascular risks, risk of hypoglycemia, metabolic changes, and cost. The objective of this systematic review is to analyze variables of interest in Type 2 diabetes including fasting blood glucose (FBG), post-prandial blood glucose (PPBG), hemoglobin A1c (HbA1c), microvascular complications, and cardiovascular outcomes in order to determine the shift towards the newer class of medications for type 2 diabetes. Methods: A systematic review was conducted using ScienceDirect as the primary source of obtaining articles. This review used PRISMA for reporting and GRACE for quality assessment of ten articles. The inclusion criteria for the review consisted of patients who were on metformin therapy for a sufficient amount of time, as defined by the trial’s protocol, and who were then initiated on either a sulfonylurea (glipizide or glimepiride) or a DPP-4 inhibitor (saxagliptin or linagliptin). The articles included in this review range from 2005-2019 that are written in English only. Exclusion criteria for this systematic review were articles in which patients were not initially started on metformin therapy, were diagnosed with Type 1 diabetes mellitus, and articles that were written in languages other than English. Results: After filtering 50 studies, 10 were selected for meeting the criteria of variables of interest. Findings suggested a significant reduction in fasting plasma glucose with 154 mg/dL + 4 mg/dL as baseline, decreasing to 132 mg/dL + 4 mg/dL with the use of glipizide & metformin combination. A similar pattern was presented with the use of saxagliptin and metformin in combination, but changes were less significant than glipizide. However, hypoglycemic events in patients who were taking glipizide with metformin versus saxagliptin with metformin; 13.4% of patients achieved HbA1c <7% without hypoglycemic events compared to 22.2% of the patients who achieved an HbA1c of <7% without hypoglycemic events. Conclusion: Despite the higher efficacious characteristics of sulfonylureas in lowering HbA1c, due to its reported hypoglycemic effects, DPP-4 inhibitors may be considered as a clinically stable choice for second-line therapy after completing maximally tolerated doses of metformin. Sulfonylureas are considered better than DPP-4 inhibitors for treatment in patients with cardiovascular disease history and hypoglycemia." @default.
• W3015680101 created "2020-04-17" @default.
• W3015680101 creator A5006041963 @default.
• W3015680101 creator A5076755843 @default.
• W3015680101 date "2020-10-13" @default.
• W3015680101 modified "2023-09-23" @default.
• W3015680101 title "Clinical Review: Safety and Efficacy Comparison between Sulfonylureas and Dipeptidyl Peptidase-4 Inhibitors as Second-Line Therapies in Type 2 Diabetes Mellitus" @default.
• W3015680101 doi "https://doi.org/10.2174/1381612826666200408095310" @default.
• W3015680101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32268860" @default.
• W3015680101 hasPublicationYear "2020" @default.
• W3015680101 type Work @default.
• W3015680101 sameAs 3015680101 @default.
• W3015680101 citedByCount "2" @default.
• W3015680101 countsByYear W30156801012021 @default.
• W3015680101 countsByYear W30156801012022 @default.
• W3015680101 crossrefType "journal-article" @default.
• W3015680101 hasAuthorship W3015680101A5006041963 @default.
• W3015680101 hasAuthorship W3015680101A5076755843 @default.
• W3015680101 hasConcept C126322002 @default.
• W3015680101 hasConcept C134018914 @default.
• W3015680101 hasConcept C2776307423 @default.
• W3015680101 hasConcept C2777180221 @default.
• W3015680101 hasConcept C2779284873 @default.
• W3015680101 hasConcept C2779555806 @default.
• W3015680101 hasConcept C2780031085 @default.
• W3015680101 hasConcept C2780282729 @default.
• W3015680101 hasConcept C2780323712 @default.
• W3015680101 hasConcept C2780668416 @default.
• W3015680101 hasConcept C2910068830 @default.
• W3015680101 hasConcept C555293320 @default.
• W3015680101 hasConcept C71924100 @default.
• W3015680101 hasConceptScore W3015680101C126322002 @default.
• W3015680101 hasConceptScore W3015680101C134018914 @default.
• W3015680101 hasConceptScore W3015680101C2776307423 @default.
• W3015680101 hasConceptScore W3015680101C2777180221 @default.
• W3015680101 hasConceptScore W3015680101C2779284873 @default.
• W3015680101 hasConceptScore W3015680101C2779555806 @default.
• W3015680101 hasConceptScore W3015680101C2780031085 @default.
• W3015680101 hasConceptScore W3015680101C2780282729 @default.
• W3015680101 hasConceptScore W3015680101C2780323712 @default.
• W3015680101 hasConceptScore W3015680101C2780668416 @default.
• W3015680101 hasConceptScore W3015680101C2910068830 @default.
• W3015680101 hasConceptScore W3015680101C555293320 @default.
• W3015680101 hasConceptScore W3015680101C71924100 @default.
• W3015680101 hasLocation W30156801011 @default.
• W3015680101 hasOpenAccess W3015680101 @default.
• W3015680101 hasPrimaryLocation W30156801011 @default.
• W3015680101 hasRelatedWork W10195258 @default.
• W3015680101 hasRelatedWork W15647580 @default.
• W3015680101 hasRelatedWork W16315462 @default.
• W3015680101 hasRelatedWork W1701345 @default.
• W3015680101 hasRelatedWork W1739382 @default.
• W3015680101 hasRelatedWork W20349743 @default.
• W3015680101 hasRelatedWork W2474835 @default.
• W3015680101 hasRelatedWork W6387984 @default.
• W3015680101 hasRelatedWork W7563278 @default.
• W3015680101 hasRelatedWork W8744681 @default.
• W3015680101 isParatext "false" @default.
• W3015680101 isRetracted "false" @default.
• W3015680101 magId "3015680101" @default.
• W3015680101 workType "article" @default.